ArticleThe Journal of clinical investigation2018

Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance.

Kwon-Ho Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.